Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 94 entries
View as:

Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04469426 Org: User:
Start: 08/15/20 End: 11/12/24 Due: 11/12/25

The Cognitive-Prefrail Syndrome and Its Association With Adverse Health Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT04240028 Org: User:
Start: 01/21/20 End: 02/01/25 Due: 02/01/26

Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03146091 Org: User:
Start: 05/20/17 End: 12/30/20 Due: 12/30/21

Association of Centre of Excellence Self-Administered Questionnaire (CESAM) Score and Frailty Levels

Phase: N/A Priority: Normal
NCT ID: NCT03962972 Org: User:
Start: 07/23/19 End: 01/01/25 Due: 01/01/26

ER2 Frailty Levels and Incident Adverse Health Events in Older Community Dwellers

Phase: N/A Priority: Normal
NCT ID: NCT04431986 Org: User:
Start: 09/01/20 End: 09/01/21 Due: 09/01/22

The OPERa Study: Evaluating QoL After Rectal Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04893876 Org: User:
Start: 01/01/23 End: 09/30/29 Due: 09/30/30

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01276899 Org: User:
Start: 09/30/10 End: - Due: -

Geriatric Inclusive Art: Effects of Painting Sessions on Older In-patients With Cognitive Decline

Phase: N/A Priority: Normal
NCT ID: NCT03624387 Org: User:
Start: 01/31/17 End: 02/28/19 Due: 02/28/20

A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00559091 Org: User:
Start: 04/30/07 End: 02/28/10 Due: 02/28/11

The Study Guide Cluster Randomized Control Trial

Phase: N/A Priority: Normal
NCT ID: NCT03312218 Org: User:
Start: 10/18/17 End: 07/01/19 Due: 07/01/20

Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders

Phase: N/A Priority: Normal
NCT ID: NCT03978650 Org: User:
Start: 07/23/19 End: 01/01/26 Due: 01/01/27

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT02041468 Org: User:
Start: 01/31/14 End: 06/30/18 Due: 06/30/19

A-Health RCT: Effects of Participatory Art-based Activity on Health of Older Community Dwellers

Phase: N/A Priority: Normal
NCT ID: NCT03679715 Org: User:
Start: 01/05/19 End: 12/01/20 Due: 12/01/21

The Hospital Elder Life Program at the Jewish General Hospital

Phase: N/A Priority: Normal
NCT ID: NCT03628014 Org: User:
Start: 02/05/18 End: 05/30/18 Due: 05/30/19

Assessment of Recovery of Functional Capillary Surface Area in Patients Undergoing a Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05719415 Org: User:
Start: 01/30/23 End: 01/30/25 Due: 01/30/26

Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective

Phase: N/A Priority: Normal
NCT ID: NCT01050621 Org: User:
Start: 01/31/10 End: 05/31/13 Due: 05/31/14

Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01676649 Org: User:
Start: 11/30/12 End: 05/31/26 Due: 05/31/27

Risk for Short-term Adverse Events in Older Emergency Department Users

Phase: N/A Priority: Normal
NCT ID: NCT03964311 Org: User:
Start: 06/04/19 End: 01/01/25 Due: 01/01/26

Motoric Cognitive Risk and Depression

Phase: N/A Priority: Normal
NCT ID: NCT03679221 Org: User:
Start: 07/24/19 End: 12/01/25 Due: 12/01/26

Vitamin Therapy in JGH Patients

Phase: N/A Priority: Normal
NCT ID: NCT01630720 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

Phase: N/A Priority: Normal
NCT ID: NCT01433328 Org: User:
Start: 01/31/12 End: 04/30/12 Due: 04/30/13

Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00558961 Org: User:
Start: 10/31/05 End: 04/30/09 Due: 04/30/10

Randomized Controlled Trial of the Meaning-Making Intervention (MMi)

Phase: N/A Priority: Normal
NCT ID: NCT01693991 Org: User:
Start: 10/31/12 End: 12/31/13 Due: 12/31/14

Frailty Heart Failure Study

Phase: N/A Priority: Normal
NCT ID: NCT03887351 Org: User:
Start: 04/30/19 End: 11/30/20 Due: 11/30/21

Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01056523 Org: User:
Start: 01/31/10 End: 01/31/15 Due: 01/31/16